Stress-related activation of Epstein-Barr virus

Brain Behavior and Immunity

Volumn 5, Issue 2, 1991, Pages 219-232

  Glaser, Ronald ^a,b   Pearson, Gary R ^c   Jones, James F ^d   Hillhouse, Joel ^a   Kennedy, Susan ^a   Mao, Hsiaoyin ^a   Kiecolt Glaser, Janice K ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE SYSTEM; MALE; NORMAL HUMAN; STRESS; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; DNA, VIRAL; EDUCATIONAL MEASUREMENT; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMAN; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; MALE; PHARYNX; STRESS, PSYCHOLOGICAL; STUDENTS, MEDICAL; SUPPORT, U.S. GOV'T, P.H.S.; VIRUS ACTIVATION;

EID: 0025823226     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/0889-1591(91)90018-6     Document Type: Article

References (55)

1. Depression correlated with cellular immunity in systemic immunodeficient Epstein-Barr virus syndrome (SIDES)
2. Induction of Epstein-Barr virus early antigens by corticosteroids: Inhibition by TPA and retinoic acid
3. Epstein-Barr virus infection in renal transplant recipients
4. The comparison of percentages in matched samples
5. DNA-DNA dot hybridization to detect Epstein-Barr virus in throat washings
6. Immunity to herpes simplex virus type 2: Cell-mediated immunity in latently infected guinea pigs
7. A prospective study of chronic herpes virus infection and recurrent herpes labialis in humans
8. Stress, loneliness, and changes in herpesvirus latency
9. Host cell regulation of induction of Epstein-Barr virus
10. Stress-related immune suppression: Health implications
11. Changes in Epstein-Barr virus antibody titers associated with aging
12. The importance of viral markers in the study of Epstein-Barr virus-associated illness
13. A restricted component of the Epstein-Barr virus early antigen complex is structurally related to ribonucleotide reductase
14. Depression anxiety and Epstein-Barr virus infection
15. Identification of a critical period during S-phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine
16. Epstein-Barr virus and blood transfusions
17. Persistent Epstein-Barr virus infection mimicking juvenile chronic myelogenous leukemia: Immunologic and hematologic studies
18. Epidemiology of cytomegalovirus infection in man
19. Effect of hydrocortisone on cell viability, Epstein-Barr virus genome expression, and interferon synthesis in human lymphoblastoid cell lines
20. Chronic Epstein-Barr virus infection
21. Psychosocial risk factors in the development of infectious mononucleosis
22. Prediction of the incidence of recurrent herpes labialis and system illness from psychosocial measures
23. Psychological and immunological predictors of genital herpes recurrence
24. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen
25. Herpesvirus hominis in renal transplant recipients
26. Significance of herpesvirus hominis in respiratory secretions of man
27. A sensitive enzyme linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens
28. Characterization of the restricted component of Epstein-Barr virus early antigens as a cytoplasmic filamentous protein
29. Hydrocortisone and some other hormones enhance the expression of HTLV-III
30. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals
31. Infectious mononucleosis: Epstein-Barr virus shedding in saliva and the oropharynx
32. Cellular immune defects to Epstein-Barr virus-determined antigens in young males
33. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies
34. Neuropeptides and their receptors A psychosomatic network
35. Antibodies to the early antigen of the Epstein-Barr virus in relation to major depression
36. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells
37. Recurrent genital herpes among women: Symptomatic vs. asymptomatic virus shedding
38. Cellular localization of an Epstein-Barr virus (EBV)-associated complement fixing antigen in producer and nonproducer lymphoblastoid cell lines
39. Latency of herpes simplex virus in absence of neutralizing antibody: Model for reactivation
40. Immunity to herpes simplex virus type 2
41. Stress and immunomodulation the role of depression and neuroendocrine function
42. Latent characteristics of selected herpesviruses
43. The chronic mononucleosis syndrome
44. Enhanced replication of human cytomegalovirus in human fibroblasts treated with dexamethasone
45. A monoclonal antibody that neutralizes Epstein-Barr virus DNA polymerase activity
46. A unique monoclonal antibody that neutralizes Epstein-Barr virus, human cytomegaovirus, human herpesvirus 6, and bacteriophage T4 DNA polymerases
47. Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus
48. In vitro analysis of the Epstein-Barr virus: Host balance in long-term renal allograft recipients
49. The expression of the Epstein-Barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell line
50. Persisting oncogenic herpesvirus induced by the tumor promoter TPA
51. Immune response to HSV infections: Virus specific antibodies in sera from patients with recurrent facial infections